In this episode, host Rachel Feltman speaks with freelance science journalist Hannah Seo about a promising new development in male contraception: a hormone-free birth control pill that reversibly stops sperm production has just passed its first human safety trial. Seo explains how the drug works, what makes it different from hormone-based methods and where it stands in clinical development.
Recommended reading:
First Hormone-Free Male Birth Control Pill Shown Safe in Early Human Trial
Male Birth Control Is in Development, but Barriers Still Stand in the Way
“Safety and Pharmacokinetics of the Non-Hormonal Male Contraceptive YCT-529,” by Nadja Mannowetz et al., in Communications Medicine, Vol. 5, Article No. 279. Published online July 22, 2025
Email us at sciencequickly@sciam.com if you have any questions, comments or ideas for stories we should cover!
Discover something new every day: subscribe to Scientific American and sign up for our daily newsletter.
Science Quickly is produced by Rachel Feltman, Fonda Mwangi, Kelso Harper and Jeff DelViscio. This episode was edited by Alex Sugiura. Shayna Posses and Aaron Shattuck fact-check the show. The theme music was composed by Dominic Smith.
Learn more about your ad choices. Visit megaphone.fm/adchoices
